Ivonescimab in advanced squamous non-small-cell lung cancer: can we raise the survival bar? Tina Casconea,† Send email to tcascone@mdanderson.org ∙ Giannis Mountzios

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01026-3/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_asco26&_hsenc=p2ANqtz-8RFIQw3ag3roNL_bE93yyUHT-zyt7zwvt7aCVfvNqOpOO55_sa8vzJwB-hTw-GATl_tlFnqQicBfJciUqeRqi5V6lWWQ&_hsmi=421795296&utm_content=421795296&utm_source=hs_email